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This study compares a rapid ImmunospecificKalazarCanineRapid Spot IFwith the gold standard test (indirect fluorescent antibody
test (IFAT)) for detection of Leishmania infantum specific IgG serum antibodies in naturally exposed dogs. Serum samples were
obtained from 89 healthy dogs and dogs affected by canine leishmaniosis (CanL). IgG-IFAT titers ≥80 were considered positive.
Anti-L. infantum IgG antibodies were found in 54 samples with titers ranging from 1 : 80 to 1 : 5120. The performance of the rapid
Immunospecific Kalazar was evaluated using a ROC curve.The area under the ROC curve of 0.957 was significantly different from
0.5 (𝑃 < 0.0001), and therefore it can be concluded that the rapid Immunospecific Kalazar has the ability to distinguish canine sera
with and without L. infantum IgG. The best performance of the test was at a cutoff >0 (sensitivity 92.6%, specificity 97%). The test
can be used for disease screening if the cutoff is >0 (highest sensitivity, 92.6%) and is recommended as confirmatory test for the
presence of L. infantum IgG antibodies if the cutoff is set >2 (highest specificity, 100%).
1. Introduction
Canine leishmaniasis (CanL) due to Leishmania infantum
infection is a life-threatening zoonotic disease with a wide
distribution in four continents and is also important in non-
endemic regions. In the Mediterranean basin canine leish-
maniasis is widespread. The disease is present in central and
southern regions of Italy, including the islands [1]. Based
on results from a recent survey, leishmaniasis is now focally
endemic in continental northern Italy [2–4].
Leishmaniasis has also been reported in northern regions
of Europe such as Germany and the UK and in the USA and
Canada [5–7]. Leishmania infantum is transmitted mainly
when infected phlebotomine sandflies (Phlebotomus spp. and
Lutzomyia spp. in the old and new world, resp.) [8] feed, and
dogs are the main reservoir for human leishmaniasis [3, 9].
The diagnosis of CanL infection is complicated by non-
specific clinical presentations and variable laboratory find-
ings. Clinical presentations range from subclinical/asympto-
matic to full-blown disease, depending on the host’s immune
response [10].
The diagnosis of CanL can be made by direct methods
such as cytological examination of samples from lymph
nodes, bone marrow, spleen, or skin, polymerase chain reac-
tion (PCR) on biological tissue or indirect methods for
detection of anti-Leishmania antibodies of which the im-
munofluorescence antibody test (IFAT) and enzyme-linked
immunosorbent assay (ELISA) are the most commonly used
techniques [9, 11–13]. High antibody levels are associatedwith
high parasitism [10] and provide a definitive diagnosis of
CanL [9]. IFAT is considered the “gold standard” method for
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serological diagnosis of CanL with a specificity of 100% for
antibody titers ≥1 : 160 [10, 12].
Immunochromatography tests have been developed to
provide a more rapid and easy to use diagnostic test, which
would also be valuable in mass screening. An immunochro-
matographic test for leishmaniasis antibody based on recom-
binant K39 (rK39), a protein predominant in Leishmania
infantum and Leishmania donovani tissue amastigotes, has
been developed for research purposes in both human and
veterinary medicine [14–18]. This test is easy to use and
provides qualitative results on the spot. In previous canine
studies [14–18] this immunochromatography kit has been
shown to have variable specificity (reported specificity from
61 to 100%) and sensitivity, and its performance is still not
optimal [16–18].
The aimof this studywas to investigate the accuracy of the
results provided by this immunochromatographic test and to
assess its sensitivity and specificity to measure L. infantum
IgG antibodies in dogs, using a ROC curve and IFAT test as
gold standard.
2. Materials and Methods
2.1. Canine Population and Samples. In order to reflect
the situations encountered in veterinary practice, the study
population was selected to have a variety of anamnestic
responses and different concentrations of serum antibodies
against Leishmania infantum. The aim was to study the test
on a population similar to that on which veterinarians in
practice would use the test. Nonfasting blood samples were
obtained from 89 canine patients, between 2 and 14 years
of age, referred to the Veterinary Clinic, Veterinary Faculty,
Milan University. Fifty-four dogs had originated in, or had
travelled to areas where canine leishmaniasis was endemic,
and of these, 40 showed signs compatible with CanL and
14 had no clinical signs nor hematological abnormalities
(anemia, thrombocytopenia), hyperproteinemia, hypergam-
maglobulinemia, and decreased albumin to globulin ratio
(A/G ratio) compatible with CanL. In all 54 dogs, L. infantum
infection was confirmed by either a positive real-time PCR
during which L. infantum DNA was amplified from 200𝜇L
of whole blood using the 92 Illustra blood genomicPrep.
Mini Spin kit (GE Healthcare, Milan, Italy) following the
manufacturer’s instructions [19] or cytological examination
and a positive test for detection of L. infantum IgG antibodies.
The control group comprised 25 clinically healthy dogs living
in nonendemic areas that had never travelled to an endemic
area, were treated annually to control filariasis, and were
negative for L. infantum infection on both PCR and IFAT
tests. In order to evaluate any possible cross-reaction with
Ehrlichia canis seropositivity, a further control group of 10
dogs was included; these were from nonendemic areas for
leishmaniasis and were negative on PCR and IFAT for L.
infantum but positive on an IFAT test for detection of E.
canis IgG antibodies. All serum samples were analyzed in a
double-blind procedure to compare the ability of an in-clinic
standardized immunochromatographic technique (Kalazar
Canine Rapid Test, Immunospec Corporation Canoga Park,
CA) to measure canine L. infantum IgG antibodies with the
standard IFAT test.
2.2. Immunochromatographic Test. The immunochromato-
graphicKalazar Canine Rapid Test is a qualitativemembrane-
based immunoassay for the detection of anti-Leishmania
antibodies in canine serum.Themembrane is precoated with
rK39-antigen on the test line region and chicken antiprotein
A on the control region.The test was performed according to
the manufacturer’s instructions. In brief the procedure was
as follows: after allowing the serum specimen and the strip to
reach room temperature, 20 𝜇L of serumwas added to the test
strip in the area beneath the arrow, the strip was then placed
vertically in a test tube. Two drops of the chase buffer solution
provided in the kit were added to the test tube. The results
were read after 10min.
The test was considered positive if 2 distinct red lines
appeared, one on the test region (regardless of the shade of
color (red or pink)) and the other on the control region.
Negative test results were reported when no line appeared
in the test region, and the test was considered invalid if no
line appeared in either the test or control region. The manu-
facturer’s guide for interpretation of results reports that the
intensity of the red color in the test region varies depending
on the concentration of anti-Leishmania antibodies present,
so the intensity of the red line was scored from 1 to 5, as
follows: negative: no line, + (result line much paler than
control line), ++ (result line paler than control line), +++
(result line equal in intensity to the control line), ++++ (result
line darker than control line), and +++++ (result line much
darker than control line).
2.3. Indirect ImmunofluorescenceAntibodyTest. TheIFAT test
was carried out as previously described [20] using a com-
mercial kit Leishmania-Spot IF (BioMe´rieux Marcy L’Etoile,
France) that uses L. infantum promastigotes as antigen.
Briefly the parasitic cells were exposed to serum diluted
in phosphate-buffered saline pH 7.2, in a damp chamber,
washed, and exposed to fluorescein labeled rabbit anti-dog
IgG (Sigma Aldrich, Munich Germany) at 37∘ for 30 minutes
in a similar incubation. The slides were then washed, dried,
and examined under a fluorescent microscope. Positive and
negative controls were included in each series of analyzed
samples. For the IFAT test cytoplasmic or membrane fluores-
cence at an antibody titer of 1 : 80 was considered positive as
indicated by manufacturer’s instructions.
The IFAT test for detection of E. canis IgG antibodies
test was performed using a commercial kit, Fluo Ehrlichia
canis (Agrolabo). Serum samples were titrated using 10 serial
twofold dilutions in PBS, starting at a 1 : 40 dilution. Diluted
serum (10 𝜇L) was placed into each well of a 12-well antigen-
coated slide containing cultured cells infected with E. canis
as antigens. A positive control serum and PBS as a negative
control were also placed in separate wells. After incubation at
37∘C for 30min, the slide was washed three times with PBS.
Then one drop of fluorescein isothiocyanate-conjugated goat
anti-dog, immunoglobulin G, was placed into each well, and
the plates were incubated at 37∘C in the dark and rinsed as
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described above. A coverslip was placed on the slide with
mounting medium, and the slide was examined under an
epifluorescent microscope. An antibody titer of 1 : 80 was
considered positive.
To establish the repeatability of the immunochromato-
graphic test, 4 canine samples with IFAT titers of negative,
1 : 80, 1 : 160, and 1 : 320, were analyzed 10 times on the same
day.
Conservability was tested by performing the immuno-
chromatographic test on 2 samples (IFAT titer 1 : 80 and
1 : 320, resp.) stored at −20∘C for 24 and 48 hours and for 7,
15, and 30 days, respectively.
2.4. Statistical Analysis. A weighted-𝑘 statistic (𝑘) with 95%
confidence interval was calculated to evaluate agreement
greater than chance alone between the 2 testing methods,
comparing between the titer of positivity of the IFAT and
the degree of positivity detected by immunochromatographic
test expressed in 5 grades of color intensity. The level of
agreement between the 2 testing methods, based on 𝑘, was
scored according to the following guidelines: 0: no better than
chance; 0.20: <poor agreement; 0.21–0.40: fair agreement;
0.41–0.60: moderate agreement; 0.61–0.80: good agreement;
0.81–1.00: very good agreement [21].
Data obtained from the immunochromatographic Kala-
zar Canine Rapid Test were checked for normal distribu-
tion using the Kolmogorov-Smirnov test, while the differ-
ence between the positive and negative groups was calcu-
lated using the Kruskal-Wallis test. The diagnostic agreement
between the two variables obtained by IFAT and Kalazar
was determined using Spearman’s coefficient of rank corre-
lation. To assess overall performance of the immunochro-
matographic test, sensitivity, specificity, negative (LR−) and
positive (LR+) likelihood ratios, negative predictive value
(PV−), and positive predictive value (PV+) were calculated
generating aROCcurve using IFAT test as criterion-reference
standard [22]. The performance of the test was analyzed by
comparing the area under the curve (AUC), 1 indicating
a perfect test and 0.5 indicating results similar to chance.
The area under the ROC curve provides a single numerical
estimate of overall accuracy that can be interpreted as the
average probability that an infected animalwill have a positive
test value compared to a noninfected animal.
When the variable being considered cannot distinguish
between the group of negative and positive, that is, where
there is no difference between the two distributions, the AUC
will be equal to 0.5, and the ROC curve will coincide with the
diagonal. When there is a perfect separation of the values of
the two groups; that is, the distributions do not overlap, the
area under the ROC curve equals 1.
All statistic analyses were performed using MedCalc for
Windows v. 9.2.1. (Mariakerke, Belgium). For all analyses,
values of 𝑃 < 0.05 were considered significant.
3. Results
Anti-L. infantum IgG antibodies were found in 54/89 samples
using the IFAT test, with titers ranging between 1 : 80 and
1 : 5120, and 51/89 samples were positive with the rapid
immunochromatographic test. Five samples gave discordant
results: one IFAT negative sample tested positive with the
rapid test and 4 positive IFAT samples tested negative with
immunochromatography (Table 1). Weighted k statistics
comparing agreement by the 2 methods in detecting the level
of anti-Leishmania antibodies were 0.228 demonstrating fair
agreement beyond chance.
Data obtained by the immunochromatographic Kalazar
Canine Rapid Test were not normally distributed (Kolmogor-
ov-Smirnov, 𝑃 < 0.001) with significant differences between
the groups of samples that tested positive and negative
for anti-Leishmania IgG antibodies (Kruskas-Wallis, 𝑃 <
0.0001). Spearman’s coefficient of rank correlation was 0.832
(95%CI: 0.754–0.886). Assessment of the ROC curve showed
anAUC (𝑊 = 0.957) relative to the Immunochromatograph-
ic test. This is very close to an AUC of 1 (which indicates
a perfect test) and significantly greater (𝑃 < 0.0001) than
the AUC that characterizes a test unable to discriminate
serum with and without L. infantum-specific IgG (𝑊 = 0.5)
(Figure 1).The ROC analysis showed that the test cutoff point
with the best sensitivity/specificity is >0 Se (92.1%; 95% CI:
82.1%–97.9%) and Sp (97.14%; 95%CI: 85%–99.5%), +LR 32.41
(95% CI: 4.7–223.1%), −LR 0.08 (95% CI: 0.08–0,2%), PPV di
98 (95%CI: 88.2–99.8%) andNPV89.4 (95%CI: 74.2–96.5%).
Neither the IFAT L. infantum test nor the immunochromato-
graphic test was positive for anti-Leishmania IgG antibodies
in the 10 samples that were positive for E. canis antibodies.
The repeatability of the immunochromatographic assay
was good. The same results were recorded in all 10 tests
repeated on the 3 samples with variation in the degree of posi-
tivity in only 3 out of 10 repeated tests on the 1 : 80 titer sample
(Table 2). The immunochromatographic assay also returned
the same result in tests performed after the different storage
periods.
4. Discussion
Canine leishmaniasis represents not only a serious veterinary
disease but also a public health problem, since dogs are the
main reservoir of the parasite and play a key role in the
transmission cycle. Early serological diagnosis is essential to
confirm disease and indicate a requirement for start therapy;
for screening clinically healthy dogs who live in or originate
from endemic regions; for the detection of subclinical carriers
in blood donor pools and to investigate the presence of
infection in epidemiological studies for surveillance control
programmes [13].
The most useful diagnostic approaches for detection of
infection in both sick and clinically healthy infected dogs
include detection of specific antileishmanial serum antibod-
ies by several serological techniques and demonstration of
the parasite DNA in tissues by molecular techniques. The
most accessible tests for the detection of specific serum anti-
bodies (IgG) are quantitative serological techniques, such as
the immunofluorescence antibody test (IFAT) and enzyme-
linked immunosorbent assay (ELISA) [23]. These tests, how-
ever, are time-consuming and require technological expertise
and specialized laboratory equipment.
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Table 1: Distribution of 89 canine serum samples according to the different antibody titers identifiedwith IFAT and immunochromatographic
assay for the detection of anti-Leishmania IgG antibodies.
IgG Immunochromatographic test IgG IFAT
<1 : 80 1 : 80 1 : 160 1 : 320 1 : 640 1 : 1280 1 : 2560 1 : 5120 Total
Result and degree of positivity
− 34 3 1 0 0 0 0 0 38
+ 0 4 2 0 0 0 0 0 6
++ 1 1 2 0 0 0 2 0 6
+++ 0 2 0 3 0 0 0 2 7
++++ 0 2 3 3 1 2 2 1 14
+++++ 0 1 3 4 4 3 2 1 18
Total 35 13 11 10 5 5 6 4 89
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40
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Figure 1: ROC curve for the immunochromatographic assay for
detection of anti-Leishmania IgG antibodies. 𝑌-axis shows the false
positive rate (specificity), and the 𝑥-axis shows the true positive rate
(sensitivity). A test with the perfect discrimination has a ROC curve
that passes through the upper left corner. The area under the curve
(AUC) is𝑊 = 0.957 (𝑃 > 0.0001). The ROC analysis shows that the
cutoff point for the test with the best sensitivity/specificity is >0 (Se:
92.1%; Sp: 97.14% expressed as percentages).
Notwithstanding the great number of techniques and
protocols currently available, many diagnostic challenges
remain especially for the practitioner, and a single easy to use
and reliable tool for disease diagnosis would be invaluable.
Immunochromatographic-based assays are easy to use
and rapid and provide qualitative results on the spot. They
require neither special preparation of the sample nor special
equipment, and the execution times are quick (10 minutes).
Additionally the Kalazar Canine Rapid Test may be stored at
ambient temperature and is suitable for field use.
Immunochromatographic test for the rapid detection of
anti-L. infantum IgG is able to distinguish canine serum sam-
ples with and without these antibodies. The best sensitivity
and specificity of the test occur for values greater than zero
that is a positive test at the lowest color intensity. The Se and
Sp of a test vary according to the cutoff value chosen, and this
may change depending on the purpose for which the test is
being used. The most important requirement when using a
test to screen for infection is sensitivity [24].The results of this
study suggest that the immunochromatographic test is useful
as a rapid screening test for the presence of L. infantum-
specific serum antibodies in dogs when a cutoff value ≥0
is used (Se 92.59%; NPV 89.5%). At this cutoff, the rapid
Kalazar Canine Rapid Test could be a useful screening
method in epidemiological studies of the seroprevalence of
canine leishmaniasis. Although in endemic areas and for
surveillance programs sensitivity is essential, in clinical cases
specificity ismore important [22]. Our results suggest that the
rapid immunochromatographic test can be used to confirm
the presence of L. infantum-specific IgG, provided that the
cutoff value for identification of clinically suspected animals
is very positive, that is, grade 2. At this level both the Sp and
PPV are 100%, eliminating the risk of identifying a healthy
animal as infected.The weighted 𝑘 statistic showed there was
fair agreement between the 2 methods with regard to the
degree of positivity.
The poor correlation between the IFAT titers and the
intensity of the positive red line on the test strip may be
caused by the different antigen profiles presented in each
test: whole parasites for IFAT test and recombinant antigen
specific for visceral leishmaniasis for the immunochromato-
graphic test that can determine a different affinity of antibod-
ies. Three of four false negative results occurred in samples
with a low positive titer using the IFAT test (1 : 80). The
presence of low antibody level is not necessarily indicative of
disease and must be evaluated in relation to clinicopatholog-
ical signs and confirmed by other tests such as parasitological
test [25].Thus, in the clinical setting, negative Kalazar Canine
Rapid Test results must always be considered in conjunction
with clinical signs, and additional diagnostic tests will be
needed for confirmation of disease in clinically suspect dogs
in which the test is negative.
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Table 2: Repeatability of the immunochromatographic assay for the detection of IgG anti-Leishmania antibodies: results obtained by
repeating the immunochromatographic test 10 times on the same sample, in four different samples, with different titles of positivity (negative,
1 : 80, 1 : 160, and 1 : 320 according to the IFAT test). The red line was more intense in 3 out of 10 repeated tests on the sample with a titer of
1 : 80.
IFAT test 1 2 3 4 5 6 7 8 9 10
Neg − − − − − − − − − −
1 : 80 ++++ +++++ ++++ ++++ ++++ +++++ +++++ ++++ ++++ ++++
1 : 160 ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++
1 : 320 +++++ +++++ +++++ +++++ +++++ +++++ +++++ +++++ +++++ +++++
5. Conclusions
In conclusion, our study shows that the Kalazar Canine Rapid
Test is useful in the clinical setting to distinguish dogs with or
without L. infantum-specific IgG if a positive result is defined
as grade 2 (the color of the red result line being slightly paler
than control line), whilst exclusion of false positives can only
be achieved if a higher level of specificity is demanded from
the test.
Perfect correlation between the degrees of agglutination
of the 2 methods would have allowed their interchangeable
use in clinical practice. On the basis of our results we suggest
that the Kalazar Canine Rapid Test is only used to confirm
disease in dogs in which there is clinical suspicion of disease.
Alternative methods, such as ELISA or IFAT, are needed to
provide a qualitative measurement of the serum antibody
concentration and an endpoint titer.
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